top of page
PRESS
Recardio at J.P. MORGAN 2024
San Francisco, January 8, 2024 - Recardio Inc., a late-stage clinical-stage life science company focusing on therapies for cardiovascular...
Jan 8, 20241 min read
Recardio at BIO-EUROPE 2023
San Francisco, November 6, 2023 - Recardio Inc., a late stage clinical-stage life science company focusing on regenerative therapies for...
Nov 6, 20231 min read
Phase 3 Heal-MI Study Published
San Francisco, July 5, 2023 - Recardio Inc., a late stage clinical stage life science company developing therapies for cardiovascular and...
Jul 4, 20232 min read
bottom of page